John de Groot, MD
@J_deGrootMD
Professor, Neuro-Oncology. Clinician, scientist, husband, dad, swimmer.Tweets are my own.
ID:4673095513
29-12-2015 13:45:15
193 Tweets
1,3K Followers
111 Following
Our newly activated trial is specifically designed for patients with oligodendroglioma (CIC mutated) and NF1-associated gliomas clinicaltrials.gov/ct2/show/NCT05…. Excited to announce this unique trial and accrue patients! #endcancer , MD Anderson Cancer Center
Really wonderful National Brain Tumor Society walk today. Nice to see so many clinicians, scientists, patients, and caregivers together! UCSF Neurosurgery UCSF Helen Diller Family Comprehensive Cancer Ctr @UCSF
William C Chen presenting his award-winning research on a biomarker that predicts #meningioma radiation response at #ASCO2023 . Photo credit to John de Groot, MD Jennie Taylor and Susan Chang! UCSF Neurosurgery UCSF Helen Diller Family Comprehensive Cancer Ctr @UCSF
Go Global Coalition for Adaptive Research! So glad National Brain Tumor Society Kirk Tanner, John Higgins, Managing Director of the Brain Tumor Investment Fund, and NBTS' volunteers will be part of this way to raise awareness during #GrayMay
The Kintara team was honored to ring the @NASDAQ #ClosingBell today alongside Global Coalition for Adaptive Research and National Brain Tumor Society in commemoration of National #BrainTumor Awareness Month. #GoGrayinMay
Learn more about our work: bit.ly/3Wmxc6G
$KTRA #KTRA
Congratulations to Global Coalition for Adaptive Research & Kintara Therapeutics, Inc. NASDAQ: KTRA for ringing the NASDAQ closing bell with our #GBMAGILE partners, patients, caregivers, and physicians united to raise awareness of the critical, unmet need for new treatment options for patients with GBM.
Thank you to everyone who joined us Nasdaq today!
National Brain Tumor Society National Foundation for Cancer Research AFCR StacheStrong Bayer | Pharmaceuticals Kazia Therapeutics Kintara Therapeutics, Inc. NASDAQ: KTRA Vigeo Therapeutics Biohaven Polaris Pharmaceuticals Brian Alexander, Sujuan Ba Patrick Wen, Ingo Mellighoff, Erik Sulman, John de Groot, MD, Andrew Lassman
Have you considered participating in a clinical trial? Get tips for navigating the process and overcoming barriers in accessing them during a free webinar. Register: bit.ly/MayWebinar23 #btsm #braintumor
MD Anderson Cancer Center
Congratulations to our department chair Edward Chang, MD, on receiving Society of Neurological Surgeons's Winn Prize! 🎉 He is the 2nd UC San Francisco neurosurgeon to be honored with this prestigious award recognizing an outstanding commitment to neuroscience research. #SNS2023 #UCSFproud CNS
GCAR Associate Clinical Scientist, Emma Viktoria Hyddmark at #AACR23 with the #GBM AGILE clinical trial in progress poster 🧠 #GBM #glioblastoma #clinicaltrial
Thanks so much UCSF Neurosurgery for being one of sponsors for an inspiring day with National Brain Tumor Society for the Northern California Brain Tumor Walk! We will keep trying to find a cure!! John de Groot, MD Manish Aghi, MD PhD RaleighLab and so many others!!
An honor to be invited and present at BrainTumorsWarsaw. Lots of fantastic science presented and discussed. Thank you prof. Bożena Kamińska-Kaczmarek and her incredible team for everything!
Very happy to share our paper in Nature Genetics reporting meningiomas are comprised of 3 DNA methylation groups with distinct outcomes, drivers, and therapeutic vulnerabilities. nature.com/articles/s4158…. RaleighLab Abrar Choudhury, MD, PhD Stephen Magill MD, PhD @chunkybungle UCSF Neurosurgery UCSF Helen Diller Family Comprehensive Cancer Ctr
Third day of the National Cancer Advisory Board Meetings National Cancer Institute. The Cancer Moonshot 1.0 will be concluding next year and the new Cancer Moonshot 2.0 is focused on the following:
Outstanding collaboration between Dr Weathers, Jennifer Wargo MD and nadim_ajami on gut microbiome in newly diagnosed GBM. Exciting new data on potential role of the microbiome on response to therapy.